NHS England has launched a cloud-based platform that links recently-retired consultants, who still hold a licence to practice, with secondary care providers
who need additional help with their waiting lists.
It has been developed to make it easier and more flexible for retired doctors to return to the health service as part of the Long Term Workforce Plan.
NHS chief executive Amanda Pritchard in June 2023 announced the NHS Emeritus pilot scheme, which is expected to help reduce long waits for elective care.
Initially, the scheme will run for a year across England, and if successful, it may be expanded to cover other work areas.
Health Minister Andrew Stephenson commented: "Returning consultants will bring invaluable experience and knowledge, and the new digital platform will match
highly-skilled consultants with the NHS trusts that require their expertise, providing high quality care and alleviating pressures on high demand areas.
Recognising her remarkable contribution in the profession of pharmacy, Christine Gilmour, the Director of Pharmacy at NHS Lanarkshire, has been designated
as a Fellow of the Royal Pharmaceutical Society (RPS).
Christine, who joined NHS Lanarkshire as trust chief pharmacist for University Hospital Hairmyres and Stonehouse in 1994. She has been in her current role as
Director of Pharmacy for 17 years now.
Considered to be one of the highest accolades in the domain of pharmacy, this fellowship recognises the distinction of an RPS member in the pharmacy career.
NHS Lanarkshire executive medical director, Dr Chris Deighan commented: "We are extremely proud of Christine. This is a fantastic achievement and recognises
all the hard work, dedication and expertise Christine has displayed across her career."
In a recent minute of meeting, the General Pharmaceutical Council (GPhC) explored the implications of its unique authority under the Regulation of
Investigatory Powers Act (RIPA), granting powers for covert surveillance.
Although never utilized, the GPhC is obligated to maintain appropriate policies for such actions.
During a recent meeting, the pharmacy regulator discussed that the use of RIPA be brought to a future Council workshop to discuss issues including the "ethical
implications of having and using the powers, the possible use of RIPA in online pharmacy investigations and retaining the powers to deal with future scenarios as
yet unknown".
Led by Chief Executive and Registrar, Duncan Rudkin, the discussion underscored the importance of having robust oversight mechanisms in place.
The inspection report provided assurance that the GPhC's policies align with regulatory requirements.
The Department of Health and Social Care (DHSC) is pushing ahead with its plans to implement a new drug tariff from April 2024. However, this move has
sparked strong opposition from Community Pharmacy England (CPE), raising concerns about its potential impact on pharmacies and patients.
Earlier, it was announced that the April drug tariff will include the new 'Retrospective top-up payment for Concessionary prices, which will be applied
automatically for the products listed in Part VIIIE each quarter by the NHS Business Services Authority (NHSBSA), according to the volume the contractor was
paid for.
However, CPE argued that the government has imposed these "untested" changes without their agreement, and strongly opposed them stating that "no recovery or
downward pressure on margin is acceptable given the financial fragility of community pharmacies."
Janet Morrison, chief executive of CPE, has voiced strong opposition to these changes, arguing that "any system expecting pharmacies to dispense at a loss"
jeopardises the sector's financial stability and compromises patient care.
The National Pharmacy Association (NPA) has urged the NHS to take urgent action to prevent faults in the IT system underpinning the government's flagship
programme.
The NHS Business Services Authority (NHSBSA) recently confirmed that the issue in the Manage Your Service (MYS) portal had been resolved, and consequently, the
deadline for submission of claims for February Pharmacy First consultations was extended until 15 March 2024.
However, NPA members said that they are still facing problems, with the portal recording fewer consultations than entered by pharmacies, potentially leaving
them out of pocket by thousands of pounds.
Paul Rees, chief executive of the NPA, highlighted the significant achievement of pharmacies in delivering tens of thousands of consultations in the first month
of the Pharmacy First programme, stating that this accomplishment is "a testament to their skill and dedication."
LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the
company's new Chief Executive Officer (CEO).
Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.
With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies.
He has also co-authored "The Little Black Book of Change."
Adams will lead the LPCH's mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within
homecare and community settings while improving accessibility.
Community Pharmacy England (CPE) has launched its third annual Pressures Survey to uncover the various challenges encountered by individuals owning or
working in a community pharmacy.
The Committee expressed concern that community pharmacies in England are now in a critical situation, significantly affecting workload, stress levels, patients,
and businesses.
The 2024 Pharmacy Pressures Survey is aimed at finding out more about these issues and other areas such as medicines supply problems and workforce challenges as
well as the recently launched Pharmacy First service, it said.
CPE chief executive Janet Morrison said that they were able to receive a huge number of responses in previous surveys and they are expecting to achieve a similar
level of engagement this year too.
In a move towards greater diversity and inclusivity, the National Pharmacy Association (NPA) has welcomed three accomplished women to its board of key members.
Aisling O'Brien, Sukhi Basra, and Sehar Shahid-who is the youngest member- have joined the board, marking a significant step in the organisation's commitment
to equality and representation.
The announcement, made on the occasion of the International Women's Day, by chief executive, Paul Rees MBE via X reflects the organisation's dedication to
celebrating and empowering women in the pharmacy profession.
Sukhi Basra, the inaugural female board member since last April, adds a valuable dimension to the NPA. With her role as a Community Pharmacy KCW committee
member and her experience in clinical pharmacy spanning over 25 years, she brings a wealth of knowledge and a distinctive viewpoint.
Community Pharmacy England (CPE) highlighted the untapped potential of community pharmacies in the prevention and management of long-term conditions to
Conservative MPs during an event last week.
The roundtable discussion was attended by a select group of influential and supportive MPs alongside community pharmacy owners, the Chief Executive of Community
Pharmacy England, the Director of NHS Services, and patient representative group Healthwatch.
MPs in attendance included Steve Double, MP for St Austell and Newquay, who chaired the discussion; Will Quince MP, former Minister for Pharmacy, Derek Thomas
MP, Sir Peter Bottomley and Peter Aldous MP.
They talked about the current pressures and funding crisis in community pharmacy, exploring solutions on how this could be eased and the huge benefits that can
be unlocked.
The government will on Thursday launch a drive to boost childhood vaccination rates, health authorities said, seeking an "urgent reversal" to a fall in
uptake as the country faces a worsening measles outbreak.
Routine childhood immunisations in Britain for diseases including measles, mumps and rubella, diphtheria and polio, have been falling gradually over the past
decade, but dipped more sharply after the Covid-19 pandemic, mirroring a global decline.
Last year UNICEF said people worldwide had lost confidence in the importance of routine childhood vaccines during the pandemic, with misinformation, dwindling
trust in governments and political polarisation contributing to rising hesitancy.
Britons will begin seeing adverts from next week across various media, including a television campaign featuring children reminding parents of the risk of missing
out on vaccinations, the UK Health Security Agency (UKHSA) said.
"We need an urgent reversal of the decline in the uptake of childhood vaccinations to protect our communities," UKHSA chief executive Jenny Harries said in a
statement.
Covid-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and
pick up market share from much larger rivals, Pfizer and Moderna.
The company posted a larger-than-expected fourth-quarter loss as revenue lagged analysts' estimates.
Chief executive John Jacobs said Novavax claimed just a low-single-digit percentage market share in the US during the most recent vaccination campaign, as demand
for Covid vaccines was smaller than hoped and the company got its protein-based shot to market later than its messenger RNA-based rivals.
"We were disappointed with that US performance," Jacobs said in an interview.
He said the company's sales force was not targeted enough toward retail pharmacy chains, and that its 5-dose vials were not as convenient for use as rivals'
pre-filled syringes.
The drop in vaccination rates is believed to be driving a surge in measles cases in England, mainly in the West Midlands.
As of 18 January, 216 confirmed cases and 103 probable cases have been reported in the region since 1 October 2023, the UK Health Security Agency (UKHSA) revealed.
The majority of cases (around 80 per cent) were from Birmingham, with children aged under 10 years being infected the most.
UKHSA Chief Executive, Professor Dame Jenny Harries has warned that the outbreak could spread further to other towns and cities if urgent action is not taken
to increase Measles, Mumps and Rubella (MMR) vaccination uptake in areas at greatest risk.
Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands
Company, a company owned by American private equity firm Yellow Wood Partners.
The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer,
valued at around $80 million.
Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt.
ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024.
Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being
rigorous and disciplined where there are opportunities for divestment.
"While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.
Eli Lilly's weight-loss medicine Mounjaro, also known as tirzepatide, will be available in the UK within weeks as a four-dose pre-filled injection pen.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the drug to treat adults with type 2 diabetes and for weight management in obese patients.
Branded as Mounjaro KwikPen, the injection is to be used together with a reduced-calorie diet and increased physical activity, the regulator said.
"The public health importance of safe and effective treatments to help manage diabetes and obesity, which can have a significant impact on people's health, is clear.
"This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month's treatment, of one dose per week," said Julian Beach,
MHRA Interim Executive Director, Healthcare Quality and Access.
Community Pharmacy England (CPE) has cautioned that patients in the UK will continue to encounter difficulties in accessing medicines unless the government
addresses supply problems and resolves the critical financial state of community pharmacies.
CPE Chief Executive Janet Morrison and Mike Dent, Director of Pharmacy Funding, on Monday 19 February, gave evidence to the Health and Social Care Select
Committee's Pharmacy Inquiry, highlighting the impact of ongoing medicines supply issues on pharmacies and patients.
Morrison indicated that a combination of the ongoing "financial squeeze, operational pressures, and medicines supply and pricing issues" has left pharmacy
businesses fighting for survival.
"As the NHS continues to grapple with wider challenges, this is a battle that patients cannot afford for pharmacies to lose," she said.
Morrison warned that if pharmacies continue to close, not only business owners and pharmacy teams will suffer, but patients and local communities will also
face the consequences.
The British Generic Manufacturers Association (BGMA) on Monday alerted the Health and Social Care Committee that medicines shortages have increased and
are "around double what they were a year ago."
BGMA chief executive Mark Samuels told the committee that they have been highlighting the medicine shortage risk to ministers since July 2021 and the association
is "very concerned" about the current situation.
"We've been monitoring it for several years now, and as you saw in the written evidence, shortages have increased. They're around double what they were a year ago.
We have them at 101 shortages in February this year," said Samuels.
Dr Rick Greville, director of distribution and supply at the Association of the British Pharmaceutical Industry (ABPI), highlighted that the problem of drug
shortages in the UK is a "long-standing issue" and the scarcity of certain medications "continues to be challenging".
"Patients deserve choice, but wherever they go they will find vacant nursing posts and overstretched services," responded Professor Pat Cullen, RCN
General Secretary and Chief Executive, to the introduction of the new pilot scheme for out-of-hospital patient care.
The NHSE and the DHSC have announced a new pilot scheme commencing in autumn "offering patients a choice of where they receive out-of-hospital care".
Under the initiative, individuals requiring treatment outside of hospitals will have the opportunity to select from a range of providers across both the NHS
and the independent sector.
Patients can select their care provider for in-hospital consultant-led services post-GP consultation, offering a choice from at least 5 providers with details
on waiting times, distance, and quality.
In a decisive move highlighting the financial strain faced by community pharmacies, the National Pharmacy Association (NPA) submitted a £108 million invoice
to the Department of Health and Social Care (DHSC) today (16 May).
According to the NPA, this substantial sum represents the amount that pharmacies in England personally covered for the dispensing of NHS medicines last month, as a
result of inadequate funding.
"The £108m figure is an average monthly figure based on the loss to pharmacy incomes over the past decade," it said.
The association believes that mass closures can be prevented only when the government stops expecting pharmacies to subsidise the cost of delivering NHS care.
NPA chief executive Paul Rees, said: "The soaring costs of dispensing medicine coupled with declining real terms funding has led to community pharmacies in
England having to subsidise the dispensing of drugs to the tune of £108m a month.
Trainee pharmacists across Great Britain are preparing to participate in Pharmacist Support's annual Trainee ACTNow Wellbeing Campaign, scheduled from
May 20th to 24th.
Organised by the charity, this initiative aims to provide essential support as trainees approach the culmination of their placements and gear up for the General
Pharmaceutical Council (GPhC) assessment.
Danielle Hunt, Chief Executive of Pharmacist Support, highlighted the campaign's focus on addressing the significant stress and pressure trainees may experience
during this critical period.
She stated: "We understand the anxiety and pressure they may feel, not only in preparing for the assessment but also in stepping into their roles as registered
pharmacists."
The National Pharmacy Association (NPA) is distributing new campaign materials to pharmacies across England this week to empower them to advocate for fair
funding in the forthcoming general election.
These include campaign posters, stickers, postcards for patients to send to MPs and petition materials.
By supplying these resources, the NPA aims to boost its cross-sector #SaveOurPharmacies campaign and help pharmacies raise local and national awareness of the
funding crisis that is forcing pharmacies to close at the rate of 10 a week.
NPA chief executive Paul Rees said: "Pharmacies are under crushing financial pressure. We want to help them join our efforts to raise the profile of the funding
crisis and make the public and politicians fully aware of the threat to our much-loved pharmacy network.